Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$15.1M Sell
247,073
-3,659
-1% -$223K 0.67% 27
2017
Q1
$15.2M Sell
250,732
-129,233
-34% -$7.84M 0.74% 29
2016
Q4
$21.3M Buy
379,965
+176,659
+87% +$10.3M 1.72% 3
2016
Q3
$12.1M Buy
203,306
+171,414
+537% +$10M 0.72% 28
2016
Q2
$1.75M Sell
31,892
-66,034
-67% -$3.51M 0.1% 237
2016
Q1
$4.94M Sell
97,926
-109,864
-53% -$5.38M 0.34% 73
2015
Q4
$10.5M Buy
207,790
+144,498
+228% +$7.29M 0.72% 23
2015
Q3
$2.98M Sell
63,292
-96,707
-60% -$5.14M 0.18% 164
2015
Q2
$8.69M Sell
159,999
-17,925
-10% -$1.01M 0.49% 47
2015
Q1
$9.76M Sell
177,924
-4,731
-3% -$268K 0.6% 41
2014
Q4
$9.9M Buy
+182,655
New +$10.2M 0.81% 20

Other funds holding MRK

Airain Ltd's MRK Position: Q2 2017 in Review

Airain Ltd reduced its Merck (MRK) stake by 1.5% in Q2 2017, selling an estimated $223K and leaving 247,073 shares worth $15.1M. The position accounts for 0.67% of the portfolio, ranked #27.

Airain Ltd first reported a position in MRK in Q4 2014 and has held it in 11 quarters since. The position peaked at $21.3M in Q4 2016. 1,925 funds tracked by Wall St. Rank hold MRK as of Q2 2017.

  • Airain Ltd held 247,073 shares of Merck worth $15.1M as of Q2 2017.
  • Airain Ltd sold 3,659 Merck shares in Q2 2017, an estimated $223K.
  • Merck made up 0.67% of Airain Ltd's portfolio in Q2 2017, its #27 holding.
  • Airain Ltd first reported a position in Merck in Q4 2014 and has held it in 11 quarters since.
  • Airain Ltd's Merck position peaked at $21.3M in Q4 2016.
  • 1,925 funds tracked by Wall St. Rank held Merck as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.